Diabetes
Conference Coverage
Normal-weight prediabetes patients also benefit from lifestyle intervention
News from the FDA/CDC
ED visits for life-threatening conditions declined early in COVID-19 pandemic
Visits for MI, stroke, and hypoglycemic crisis dropped 10%-23% over the first 10 weeks.
Conference Coverage
T2D plus heart failure packs a deadly punch
Medical records from 150,000 Danish patients with type 2 diabetes showed heart failure comorbidity was the deadliest combination.
News
FDA approves metoclopramide nasal spray for diabetic gastroparesis
Feature
Cost of preventable adult hospital stays topped $33 billion in 2017
Heart failure, diabetes, and COPD were the most expensive preventable conditions.
Latest News
Daily Recap: Headache as COVID evolution predictor; psoriasis drug treats canker sores
“From an individual level we can now say that in healthy individuals, a systolic pressure in the 90s is not too low. It is a positive thing.”
News
Lyumjev ultra-rapid-acting insulin gets FDA nod
The novel rapid-acting formulation of insulin lispro is approved for adults with type 1 and type 2 diabetes.
From the Journals
Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?
Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that...
Conference Coverage
Dapagliflozin’s T2D renal protection extends to ‘fast decline’ of eGFR
Another dimension of dapagliflozin’s renal protection for type 2 diabetes patients is shown in a post-hoc analysis from its cardiovascular...
Conference Coverage
VERTIS-CV: Ertugliflozin’s CV outcomes trial confirms SGLT2i benefits
Conference Coverage
Frequent hypoglycemic episodes raise cardiac event risk
It’s “essential” to avoid drugs associated with hypoglycemia to minimize CV event risk in patients with type 2 diabetes, investigator says.